IRIS
PICCHIO, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.545
NA - Nord America 7.141
AS - Asia 6.347
SA - Sud America 1.684
AF - Africa 144
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 8
Totale 22.893
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.895
RU - Federazione Russa 3.801
SG - Singapore 2.269
CN - Cina 1.883
BR - Brasile 1.340
SE - Svezia 834
HK - Hong Kong 786
IT - Italia 783
VN - Vietnam 617
RO - Romania 536
ES - Italia 347
FR - Francia 329
BD - Bangladesh 269
DE - Germania 252
GB - Regno Unito 177
FI - Finlandia 147
AR - Argentina 141
CA - Canada 125
IN - India 112
MX - Messico 83
PL - Polonia 73
ID - Indonesia 63
EC - Ecuador 59
NL - Olanda 59
ZA - Sudafrica 57
TR - Turchia 50
IE - Irlanda 49
IQ - Iraq 45
JP - Giappone 43
AT - Austria 41
CO - Colombia 36
PY - Paraguay 28
MD - Moldavia 27
CL - Cile 22
PE - Perù 22
AU - Australia 21
NP - Nepal 21
PK - Pakistan 21
UA - Ucraina 20
MY - Malesia 18
SA - Arabia Saudita 18
VE - Venezuela 18
MA - Marocco 17
UZ - Uzbekistan 17
JO - Giordania 14
PH - Filippine 14
DZ - Algeria 13
IR - Iran 13
KE - Kenya 13
EG - Egitto 11
LT - Lituania 11
AE - Emirati Arabi Uniti 10
AZ - Azerbaigian 10
BE - Belgio 10
IL - Israele 10
TN - Tunisia 10
UY - Uruguay 10
PT - Portogallo 9
BO - Bolivia 7
CZ - Repubblica Ceca 7
EU - Europa 6
KZ - Kazakistan 6
RS - Serbia 6
AL - Albania 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
JM - Giamaica 5
OM - Oman 5
TW - Taiwan 5
CI - Costa d'Avorio 4
GR - Grecia 4
GT - Guatemala 4
LB - Libano 4
PS - Palestinian Territory 4
SN - Senegal 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
CH - Svizzera 3
CR - Costa Rica 3
CY - Cipro 3
HN - Honduras 3
HU - Ungheria 3
KR - Corea 3
LV - Lettonia 3
PA - Panama 3
SC - Seychelles 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AO - Angola 2
BB - Barbados 2
BZ - Belize 2
KH - Cambogia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
SV - El Salvador 2
XK - ???statistics.table.value.countryCode.XK??? 2
AW - Aruba 1
BH - Bahrain 1
Totale 22.877
Salva come PNG Salva come JPEG
Città #
Dallas 3.105
Singapore 957
Moscow 804
Hong Kong 771
Ashburn 663
San Jose 595
Shanghai 371
Valencia 303
Hefei 299
Milan 284
Beijing 262
New York 261
Lauterbourg 251
Lawrence 244
Princeton 244
Ho Chi Minh City 203
Hanoi 149
Los Angeles 118
São Paulo 116
Munich 100
Santa Clara 79
Orem 78
Helsinki 73
Boardman 72
Turku 59
Warsaw 49
Dublin 48
Brooklyn 45
Rome 45
Rio de Janeiro 39
Montreal 35
Chennai 34
Chicago 34
Da Nang 34
Tokyo 34
Frankfurt am Main 33
Denver 31
Johannesburg 31
Seattle 29
Stockholm 29
Buffalo 28
Manchester 28
The Dalles 28
Washington 28
Atlanta 27
Belo Horizonte 27
London 27
Poplar 27
Toronto 27
Mexico City 26
Haiphong 25
Nuremberg 24
Amsterdam 22
Guangzhou 22
Quito 22
West Jordan 22
Ankara 21
Curitiba 21
Naples 21
Phoenix 21
Brasília 20
Houston 20
Dhaka 19
Council Bluffs 17
Lima 17
Shenzhen 17
Baghdad 16
Tashkent 16
Vienna 16
Barnet 15
Columbus 15
Guayaquil 15
Las Vegas 15
Ninh Bình 15
Buenos Aires 14
Can Tho 14
Guarulhos 14
Manaus 14
New Delhi 14
Asunción 13
Boston 13
Campinas 13
Charlotte 13
Mumbai 13
Philadelphia 13
Porto Alegre 13
Amman 12
Goiânia 12
Hangzhou 12
Jakarta 12
Lappeenranta 12
Turin 12
Bexley 11
Biên Hòa 11
Bogotá 11
Cape Town 11
Falkenstein 11
Fortaleza 11
Ribeirão Preto 11
Salvador 11
Totale 12.059
Salva come PNG Salva come JPEG
Nome #
(11)C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms 1.429
11C-choline PET/CT and PSA kinetics 1.395
18F-FDG PET/CT May Predict Tumor Type and Risk Score in Gestational Trophoblastic Disease 271
18F-FDG PET/MRI in endometrial cancer: systematic review and meta-analysis 193
11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy 190
Pelvic/Retroperitoneal Salvage Lymph Node Dissection for Patients Treated With Radical Prostatectomy With Biochemical Recurrence and Nodal Recurrence Detected by [11C]Choline Positron Emission Tomography/Computed Tomography 187
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 184
68Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine well-differentiated tumours 179
11C-choline PET/CT predicts survival in prostate cancer patients with PSA < 1 NG/ml 166
Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer 160
A Single-Center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors 160
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 159
[C-11]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy 157
68Ga-DOTA-peptides PET/MRI in pancreatico-duodenal neuroendocrine tumours: a flash pictorial essay on assets and lacks 148
[ 11C] Choline PET/CT Predicts Prostate Cancer-Specific Survival in Patients with Biochemical Failure During Androgen Deprivation Therapy 145
11C-choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients 143
18F-FAZA PET/CT in pretreatment assessment of hypoxic status in high-grade glioma: correlation with hypoxia immunohistochemical biomarkers 143
11C-CHOLINE-POSITRON EMISSION TOMOGRAPHY/ COMPUTERISED TOMOGRAPHY FOR PREOPERATIVE LYMPH- NODE STAGING IN INTERMEDIATE-RISK AND HIGH-RISK PROSTATE CANCER: COMPARISON WITH CLINICAL STAGING NOMOGRAMS 140
A Prospective Observational Study on the Efficacy and Safety of Infliximab-Biosimilar (CT-P13) in Patients With Takayasu Arteritis (TAKASIM) 136
Radiomics in pancreatic neuroendocrine tumors: methodological issues and clinical significance 135
18F-FDG uptake by prosthetic arterial grafts in large vessel vasculitis is not specific for active disease: results from a cohort study 134
External validation of a convolutional neural network for the automatic segmentation of intraprostatic tumor lesions on 68Ga-PSMA PET images 131
18F-FDG PET/CT and urothelial carcinoma: Impact on management and prognosis—a multicenter retrospective study 129
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors 128
[11C]CHOLINE PET/CT for Early Detection of Tumor in Prostate Cancer Patients with PSA Level Lower Than 1.5 NG/ML 128
[C-11] Choline Positron Emission Tomography/Computerized Tomography for Early Detection of Prostate Cancer Recurrence in Patients with Low Increasing Prostate Specific Antigen 128
18F-FAZA PET/CT in the Preoperative Evaluation of NSCLC: Comparison with 18F-FDG and Immunohistochemistry 127
null 126
Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort 126
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool 124
Preliminary results of an ongoing prospective clinical trial on the use of68ga-psma and68ga-dota-rm2 pet/mri in staging of high-risk prostate cancer patients 124
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 122
18F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu’s arteritis 122
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 119
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 119
18F-FAZA PET/CT Hypoxia Imaging of High-Grade Glioma Before and After Radiotherapy 119
Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours 118
18F-FAZA PET imaging in tumor hypoxia: A focus on high-grade glioma 118
Decoding the Heterogeneity of Malignant Gliomas by PET and MRI for Spatial Habitat Analysis of Hypoxia, Perfusion, and Diffusion Imaging: A Preliminary Study 117
18F-FDG PET/CT AND UROTHELIAL CARCINOMA: IMPACT ON MANAGEMENT AND PROGNOSIS—A MULTICENTER RETROSPECTIVE STUDY IN BOOK ROLE OF MEDICAL IMAGING IN CANCERS 117
11C-Choline PET/CT based Helical Tomotherapy as Treatment Approach for Bone Metastases in Recurrent Prostate Cancer Patients 117
Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy 116
Hypoxia pathway: 18F-FAZA 116
[11C]choline PET/CT for the detection of tumor recurrence in prostate cancer patients with PSA<1.5 ng/mL 116
Prostate-specific antigen velocity versus prostate-specific antigen doubling time for prediction of 11C choline PET/CT in prostate cancer patients with biochemical failure after radical prostatectomy 115
[F-18]fluorodeoxyglucose positron emission tomography as a useful indicator of metastatic gestational trophoblastic tumor: preliminary results in three patients 115
[11C]CHOLINE PET/CT FOR RESTAGING PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY AND NO EVIDENCE OF DISEASE ON CONVENTIONAL IMAGING 114
11C-or18F-Choline PET/CT for imaging evaluation of biochemical recurrence of prostate cancer 114
[¹⁸F]fluorodeoxyglucose positron emission tomography/computed tomography and trophoblastic disease: the gynecologist perspective 113
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study 112
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters 110
Effectiveness and safety of infliximab dose escalation in patients with refractory Takayasu arteritis: A real-life experience from a monocentric cohort 110
18F-FDG PET/CT in gastric MALT lymphoma: a bicentric experience 109
PSMA PET in brain metastases: navigating diagnostic challenges– a thorough exploration 108
State of the art of radiomic analysis in the clinical management of prostate cancer: A systematic review 108
[C-11]choline-PET-guided helical tomotherapy and estramustine in a patient with pelvic-recurrent prostate cancer: local control and toxicity profile after 24 months 105
Systematic Review and Metanalysis on the Role of Prostate-Specific Membrane Antigen Positron Emission Tomography/Magnetic Resonance Imaging for Intraprostatic Tumour Assessment 104
When to Perform Bone Scan in Patients with Newly Diagnosed Prostate Cancer: External Validation of the Currently Available Guidelines and Proposal of a Novel Risk Stratification Tool 104
Role of Machine Learning (ML)-Based Classification Using Conventional 18F-FDG PET Parameters in Predicting Postsurgical Features of Endometrial Cancer Aggressiveness 102
Advanced ovarian carcinoma: usefulness of [(18)F]FDG-PET in combination with CT for lesion detection after primary treatment 102
Diagnosis of local recurrence after radical prostatectomy 101
18F-FDG positron emission tomography compared with computed tomography in diagnosing recurrent ovarian carcinoma 99
Radiomics and artificial intelligence 98
Hypoxia PET imaging beyond 18F-FMISO in patients with high-grade glioma: 18F-FAZA and other hypoxia radiotracers 98
External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography 97
Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis 96
The Challenge of External Generalisability: Insights from the Bicentric Validation of a [68Ga]Ga-PSMA-11 PET Based Radiomics Signature for Primary Prostate Cancer Characterisation Using Histopathology as Reference 95
18Fluorodeoxyglucose Positron Emission Tomography (18FDG-PET)-Guided Target Delineation in Lung Cancer 95
Synergic role of preoperative 18F-fluorodeoxyglucose PET and MRI parameters in predicting histopathological features of endometrial cancer 94
CRITICAL ASSESSMENT OF THE PERFORMANCE OF PSA KINETICS FOR THE PREDICTION OF [11C]CHOLINE PET/CT IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY 93
The Role of Choline Positron Emission Tomography/Computed Tomography in the Management of Patients with Prostate-Specific Antigen Progression After Radical Treatment of Prostate Cancer 93
PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature 93
18F-FDG PET/CT AND UROTHELIAL CARCINOMA: IMPACT ON MANAGEMENT AND PROGNOSIS—A MULTICENTER RETROSPECTIVE STUDY 90
3D Spatial resolution proprieties of Molecubes β-Cube: Characterization with different isotopes 88
Dual tracer 68Ga-DOTATOC and 18F-FDG PET/computed tomography radiomics in pancreatic neuroendocrine neoplasms: An endearing tool for preoperative risk assessment 85
[C-11]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy 84
Choline PET/CT features to predict survival outcome in high risk prostate cancer restaging: a preliminary machine-learning radiomics study 84
FDG Uptake by Prosthetic Arterial Grafts in Large Vessel Vasculitis Is Not Specific for Active Disease 81
Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers 80
Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study 79
Predictive value of 18F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study 78
Concomitant Lung Cancer and Gastrointestinal Stromal Tumor: First Report of Hypoxia Imaging With 18F-FAZA PET/CT 76
18F-FDG PET/CT for Early Postradiotherapy Assessment in Solitary Bone Plasmacytomas 75
Imaging in evaluation of response to neo-adjuvant treatment 75
Combined Use of TBNA and EBUS-TBNA in the Preoperative Staging of Lung Cancer Patients 74
18FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY (18FDG-PET)-GUIDED TARGET DELINEATION IN LUNG 74
The potential role of osteoporosis in unspecific [18F]PSMA-1007 bone uptake 73
Increased Choline Uptake in Bronchioalveolar Cell Carcinoma with Negative FDG Uptake. A PET/CT and Pathology Study 73
Hypoxia and Amino Acid Imaging of High-Grade Glioma18F-FAZA PET/CT and 11C-Methionine PET/MRI 72
Radiation treatment of lymph node recurrence from prostate cancer: Is 11C-choline PET/CT predictive of survival outcomes? 69
VALIDAZIONE TRAMITE LINFOADENECTOMIA PELVICA E RETROPERITONEALE DELLA ACCURATEZZA DELLA TC/PET CON 11CCOLINA NELLA DIAGNOSI DI METASTASI LINFONODALI IN PAZIENTI CON RECIDIVA BIOCHIMICA DI CARCINOMA PROSTATICO DOPO PROSTATECTOMIA RADICALE 68
Detection and compensation of organ/lesion motion using 4D-PET/CT respiratory gated acquisition techniques 68
First evaluation of PET-based human bioDistribution and dosimetry of 18F-FAZA, a tracer for imaging tumor hypoxia 68
Combined 68Ga-DOTA-peptides and 18F-FDG PET in the diagnostic work-up of neuroendocrine neoplasms (NEN) 68
Dual tracer 68ga-dotatoc and 18f-fdg pet improve preoperative evaluation of aggressiveness in resectable pancreatic neuroendocrine neoplasms 68
Development of a new toolbox for mouse PET-CT brain image analysis fully based on CT images and validation in a PD mouse model 68
Nuclear medicine in prostate cancer management 67
The role of 18F-FAZA PET/CT in detecting lymph node metastases in renal cell carcinoma patients: a prospective pilot trial 67
Prognostic role of FDG PET-derived parameters in preoperative staging of endometrial cancer 66
Bone metastases are infrequent in patients with newly diagnosed prostate cancer: Analysis of their clinical and pathologic features 65
Totale 13.741
Salva come PNG Salva come JPEG
Categoria #
all - tutte 128.016
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 128.016
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/2022222 1 11 1 96 14 7 13 12 18 29 5 15
2022/20231.532 543 314 123 36 23 178 81 124 43 31 5 31
2023/20241.006 52 45 149 102 66 168 36 104 12 60 54 158
2024/20254.332 529 66 65 99 141 302 1.162 285 584 441 288 370
2025/202615.986 927 1.466 3.291 1.935 924 351 1.169 889 3.388 731 459 456
Totale 23.352